{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ryanodine : Questions médicales les plus fréquentes",
"headline": "Ryanodine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ryanodine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-07",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ryanodine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pyrroles",
"url": "https://questionsmedicales.fr/mesh/D011758",
"about": {
"@type": "MedicalCondition",
"name": "Pyrroles",
"code": {
"@type": "MedicalCode",
"code": "D011758",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.129.578"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Ryanodine",
"alternateName": "Ryanodine",
"code": {
"@type": "MedicalCode",
"code": "D012433",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takashi Murayama",
"url": "https://questionsmedicales.fr/author/Takashi%20Murayama",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan."
}
},
{
"@type": "Person",
"name": "Nagomi Kurebayashi",
"url": "https://questionsmedicales.fr/author/Nagomi%20Kurebayashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan."
}
},
{
"@type": "Person",
"name": "Zhiguang Yuchi",
"url": "https://questionsmedicales.fr/author/Zhiguang%20Yuchi",
"affiliation": {
"@type": "Organization",
"name": "Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072,China."
}
},
{
"@type": "Person",
"name": "Andrew R Marks",
"url": "https://questionsmedicales.fr/author/Andrew%20R%20Marks",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hadiatullah Hadiatullah",
"url": "https://questionsmedicales.fr/author/Hadiatullah%20Hadiatullah",
"affiliation": {
"@type": "Organization",
"name": "Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072,China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Numerical simulations of the soliton dynamics for a nonlinear biological model: Modulation instability analysis.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36795692",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0281318"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deep multi-modal learning for joint linear representation of nonlinear dynamical systems.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896569",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-15669-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reconstruction of sparse recurrent connectivity and inputs from the nonlinear dynamics of neuronal networks.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35849304",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10827-022-00831-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dynamic event-triggered controller design for nonlinear systems: Reinforcement learning strategy.",
"datePublished": "2023-04-19",
"url": "https://questionsmedicales.fr/article/37099897",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neunet.2023.04.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Experimental evidence that rill-bed morphology is governed by emergent nonlinear spatial dynamics.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36513727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-26114-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Azoles",
"item": "https://questionsmedicales.fr/mesh/D001393"
},
{
"@type": "ListItem",
"position": 5,
"name": "Pyrroles",
"item": "https://questionsmedicales.fr/mesh/D011758"
},
{
"@type": "ListItem",
"position": 6,
"name": "Ryanodine",
"item": "https://questionsmedicales.fr/mesh/D012433"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ryanodine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ryanodine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ryanodine",
"description": "Comment le ryanodine est-il utilisé dans le diagnostic médical ?\nQuels tests peuvent impliquer le ryanodine ?\nLe ryanodine aide-t-il à diagnostiquer des maladies spécifiques ?\nQuels marqueurs sont affectés par le ryanodine ?\nLe ryanodine est-il utilisé dans des études cliniques ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Nonlinear+Dynamics&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ryanodine",
"description": "Quels symptômes sont associés à une dysfonction du ryanodine ?\nLe ryanodine peut-il provoquer des effets secondaires ?\nComment le ryanodine affecte-t-il le cœur ?\nY a-t-il des symptômes neurologiques liés au ryanodine ?\nLe ryanodine influence-t-il la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Nonlinear+Dynamics&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ryanodine",
"description": "Comment prévenir les effets indésirables du ryanodine ?\nY a-t-il des recommandations alimentaires pour les utilisateurs de ryanodine ?\nLes patients doivent-ils éviter certains médicaments avec le ryanodine ?\nComment évaluer le risque d'effets secondaires ?\nLe suivi médical est-il important lors de l'utilisation du ryanodine ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Nonlinear+Dynamics&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ryanodine",
"description": "Comment le ryanodine est-il utilisé en traitement ?\nLe ryanodine est-il administré par voie orale ?\nQuels médicaments interagissent avec le ryanodine ?\nLe ryanodine est-il utilisé en anesthésie ?\nY a-t-il des alternatives au ryanodine ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Nonlinear+Dynamics&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ryanodine",
"description": "Quelles complications peuvent survenir avec le ryanodine ?\nLe ryanodine peut-il causer des dommages permanents ?\nComment gérer les complications liées au ryanodine ?\nLes complications sont-elles prévisibles ?\nLe ryanodine peut-il interagir avec d'autres traitements ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Nonlinear+Dynamics&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ryanodine",
"description": "Quels sont les facteurs de risque liés au ryanodine ?\nL'âge influence-t-il les risques associés au ryanodine ?\nY a-t-il des prédispositions génétiques au ryanodine ?\nLes habitudes de vie affectent-elles les risques ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D012433?mesh_terms=Nonlinear+Dynamics&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le ryanodine est-il utilisé dans le diagnostic médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé pour évaluer les dysfonctionnements du calcium dans les muscles."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent impliquer le ryanodine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de contraction musculaire et des études de flux calcique peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Le ryanodine aide-t-il à diagnostiquer des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut aider à diagnostiquer des myopathies liées à des anomalies du calcium."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont affectés par le ryanodine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut influencer les niveaux de calcium intracellulaire et les enzymes musculaires."
}
},
{
"@type": "Question",
"name": "Le ryanodine est-il utilisé dans des études cliniques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est utilisé dans des études sur les troubles musculaires et cardiaques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une dysfonction du ryanodine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crampes musculaires, une faiblesse et des douleurs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le ryanodine peut-il provoquer des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme des troubles de la contraction musculaire peuvent se produire."
}
},
{
"@type": "Question",
"name": "Comment le ryanodine affecte-t-il le cœur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut provoquer des arythmies en modifiant le flux calcique dans les cardiomyocytes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés au ryanodine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des tremblements ou des spasmes peuvent être observés."
}
},
{
"@type": "Question",
"name": "Le ryanodine influence-t-il la respiration ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction musculaire peut affecter les muscles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables du ryanodine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance médicale régulière et un ajustement de la dose sont essentiels."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires pour les utilisateurs de ryanodine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée en calcium et en électrolytes est recommandée."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains médicaments avec le ryanodine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les médicaments qui affectent le calcium sans avis médical."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'effets secondaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests réguliers de la fonction musculaire et cardiaque sont conseillés."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important lors de l'utilisation du ryanodine ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet de détecter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Comment le ryanodine est-il utilisé en traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé pour traiter certaines myopathies et troubles du calcium."
}
},
{
"@type": "Question",
"name": "Le ryanodine est-il administré par voie orale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est généralement administré par injection ou perfusion intraveineuse."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec le ryanodine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments affectant le calcium, comme les bloqueurs des canaux calciques, peuvent interagir."
}
},
{
"@type": "Question",
"name": "Le ryanodine est-il utilisé en anesthésie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé pour prévenir des complications musculaires pendant l'anesthésie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives au ryanodine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres agents modulant le calcium peuvent être utilisés selon les besoins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le ryanodine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des arythmies et des troubles musculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le ryanodine peut-il causer des dommages permanents ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dommages permanents sont rares mais possibles en cas d'utilisation prolongée."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées au ryanodine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention médicale rapide et un ajustement du traitement sont nécessaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles avec une surveillance adéquate."
}
},
{
"@type": "Question",
"name": "Le ryanodine peut-il interagir avec d'autres traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interactions avec d'autres traitements peuvent augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque liés au ryanodine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles musculaires et cardiaques augmentent les risques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les risques associés au ryanodine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets du ryanodine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques au ryanodine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions génétiques peuvent augmenter la sensibilité au ryanodine."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie affectent-elles les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme ou l'alcool peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent exacerber les effets indésirables du ryanodine."
}
}
]
}
]
}
This article deals with studying the dynamical behavior of the DNA model proposed by Peyrard and Bishop. The proposed model is investigated using the unified method (UM). Unified method successfully e...
Dynamical systems pervasively seen in most real-life applications are complex and behave by following certain evolution rules or dynamical patterns, which are linear, non-linear, or stochastic. The un...
Reconstructing the recurrent structural connectivity of neuronal networks is a challenge crucial to address in characterizing neuronal computations. While directly measuring the detailed connectivity ...
The current investigation aims at the optimal control problem for discrete-time nonstrict-feedback nonlinear systems by invoking the reinforcement learning-based backstepping technique and neural netw...
Past experimental work found that rill erosion occurs mainly during rill formation in response to feedback between rill-flow hydraulics and rill-bed roughness, and that this feedback mechanism shapes ...
Maintaining a healthy gait into old age is key to preserving the quality of life and reducing the risk of falling. Nonlinear dynamic analyses (NDAs) are a promising method of identifying characteristi...
Medline Ovid and Web of Science databases were searched. Forty-six papers were included for full-text review. Data extracted included participant and study design characteristics, fall risk assessment...
Among all nonlinear dynamic measures, Lyapunov Exponent (LyE) was most common, followed by entropy and then Fouquet Multipliers (FMs) measures. LyE and Multiscale Entropy (MSE) measures distinguished ...
Future studies should develop a standard procedure to apply and estimate LyE and entropy to quantify gait characteristics. This will enable the development of reference values in estimating the risk o...
The complex financial networks, with their nonlinear nature, often exhibit considerable noises, inhibiting the analysis of the market dynamics and portfolio optimization. Existing studies mainly focus...
For nonlinear systems subjected to external disturbances, an adaptive terminal sliding mode control (TSM) approach with fixed-time convergence is presented in this paper. The introduction of the fixed...
This manuscript is devoted to investigate the mathematical model of fractional-order dynamical system of the recent disease caused by Corona virus. The said disease is known as Corona virus infectious...
Cerebral palsy (CP) is characterized by spasticity and muscle contracture development and associated with mild to severe motor impairments including reduced gait function. Treatment with the Exopulse®...
Twelve patients (mean age: 12 years, range 7-17 years) with unilateral CP (GMFCS level 1 and 2) received 24 weeks Exopulse® suit treatment with patient-specific muscle stimulation. Before and after th...
The largest Lyapunov exponent (p-value = 0.041) and the complexity index (p-value = 0.030) of the acceleration in the anterior-posterior direction was significantly lower post-treatment. No other betw...
The present study suggests that 24 weeks of Exopulse® suit treatment alters the nonlinear dynamics but not the variability of the trunk accelerations during walking in children with unilateral CP. The...